The official journal of CSACI
Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
Limited information is available on the clinical course of patients with severe asthma following discontinuation of biologic treatment. Therefore, a post hoc analysis was conducted in patients with severe eosi...
Citation: Allergy, Asthma & Clinical Immunology 2019 15:37